Company intelligence / Profile preview
Apgar Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
Overview
Apgar Pharmaceuticals is an Indian pharmaceutical company focused on the development, manufacturing, and distribution of high-quality generic medications and specialty healthcare products. The company specializes in critical therapeutic areas, including cardiovascular care, diabetic care, and neuro-care, aiming to provide affordable and accessible treatment options to patients globally. Headquartered in Bangalore, Apgar Pharmaceuticals maintains a commitment to quality and compliance throughout the drug development lifecycle, from research and development to commercial sales. The firm emphasizes research-driven solutions to optimize business operations in the biopharmaceutical and generics industry.
- Therapeutic areas
- EndocrinologyCardiovascularNeurologyOther
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Apgar Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apgar Pharmaceuticals.